Transparency Market Research (TMR) has published a new report titled, ‘Cell culture media, sera, and reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global cell culture media, sera, and reagents market was valued at US$ 4,987.7 Mn in 2018 and is projected to expand at a CAGR of 5.7% from 2019 to 2027.
Overview
- The global cell culture media, sera and reagents market is witnessing impressive growth due to the increase in demand for biopharmaceutical products. Since its introduction as an integral part of the life sciences industry, the cell culture market has witnessed significant growth in terms of scope as well as adoption by the end-users.
- The double-digit growth in the biotechnology and biopharmaceutical industries is the major factor likely to boost the growth of the cell culture media, sera and reagents market in the near future.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6598
Growing Demand for Biopharmaceuticals and Artificial Organs to Drive Market
- The current USD 200billion plus global biological drugs market comprises hormones, vaccines, monoclonal antibodies, therapeutic enzymes, blood factors, etc. The limited applicability of conventional pharmaceuticals in curing diseased or injured tissues has led to an increasing demand for the biologics mentioned above.
- The incredible specificity of biopharmaceuticals has opened new avenues in health care such as personalized medicine, wherein various diseases or conditions can be treated using specific biomolecules depending upon the patient’s physiological, biological, and genetic makeup.
- Limited competition from generics (called biosimilars) is also fueling market growth, as these drugs are developed using unique processes involving growth of live cell cultures under controlled environmental conditions.
- Artificial organs are engineered biological substitutes used to replace the structure and restore the functions of an impaired or diseased organ. The market for these artificial organs is expected to grow at a double digit CAGR of 25% in the near future, indicating an increasing demand and strong growth potential in the cell culture market.
- Cell-based applications of regenerative medicine include development of artificial organs and tissue and bone grafts to restore lost body functions. Development of specialty growth media and culture techniques that ensure specificity and availability of high end technology for scaling up cultures are important factors that would drive the market growth in these segments.
Request for Analysis of COVID19 Impact on Cell Culture Media, Sera, and Reagents Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=6598
Classical Media Segment to Dominate Market
- Based on media type, the global cell culture media, sera, and reagents market has been divided into chemically-defined, classical, Lysogeny Broth (LB), protein-free, serum-free, and specialty. The classical media segment accounted for majority share of the global cell culture media, sera, and reagents market in 2018.
- A classical cell culture media contains a mixture of specific nutrients such as acids, salts, vitamins, and sugar mixed in a buffered physiological saline solution. The constituents of basal media are defined on the basis of the type of culture system being used and the nature of cells to be cultured.
Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=6598
Fetal Bovine to be Highly Lucrative Segment
- In terms of product, the global cell culture media, sera, and reagents market has been classified into fetal bovine, newborn calf and adult bovine, and others.
- Serum is commonly used as a supplement in cell culture media. Sera provides wide range of macromolecules, trace elements, carrier proteins, spreading factors, hormones, low molecular weight nutrients and other growth factors. Fetal bovine serum (FBS) is the most common sera type used in cell culture medium.
- Fetal bovine serum (FBS) is the remnant blood fraction drawn from bovine fetus. FBS is a widely used serum supplement for in vitro cell culture of eukaryotic cells.
Buy now Cell Culture Media, Sera, and Reagents Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=6598<ype=S
North America to Dominate Global Market
- In terms of region, the global cell culture media, sera, and reagents market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global cell culture media, sera, and reagents market in 2018, followed by Europe.
- It is driven by a large patient pool suffering from malignant diseases such as leukemia and lymphoma, bacterial and viral infections, and metabolic diseases as well as research and development projects for drug discovery that are currently underway.
- The emerging economies of Asia Pacific, the Middle East, Latin America, and Africa are anticipated to be major contributors to the growth of cell culture market during the forecast period.
Competitive Landscape
- The global cell culture media, sera, and reagents market is fragmented in terms of number of players. Key players in the global market include Sigma-Aldrich Corporation, BD Biosciences, EMD Millipore, Thermo Fisher Scientific, Inc., GE Healthcare, Lonza Biosciences, VWR International, and Corning incorporated, Eppendorf AG., HiMedia Laboratories, WuXi AppTec, Sumitomo Bakelite Co., Ltd., PAA Laboratories, PromoCell GmbH, and Takara Bio, Inc., among others.
More Trending Reports by Transparency Market Research:
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
Transparency Market Research (TMR) has published a new report titled, ‘Osteoporosis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.
According to the report, the global Osteoporosis Drugs market was valued at US$ 11.5 Bn in 2018 and is projected to contract at a CAGR of 0.3% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=133OverviewOsteoporosis is a chronic and life-threatening disease, in which microstructure of bones is altered due to reduction in bone mass and bone density.
This condition leads to increased bone fragility and threat of bone cracks and fractures.
Since there is no distinct substitute available to treat osteoporosis (such as, surgery), the drugs therapy is an inevitable part of osteoporosis treatmentGrowing aging population leads for higher prevalence of osteoporosis which brings more growth opportunities for osteoporosis drugs market.North America dominated the global osteoporosis drugs market in 2018and the trend is anticipated to continue during the forecast period.
Higher osteoporosis incidence & prevalence rate, presence of major companies, and better diagnosis rate for the diseases are some of the major factors to dive the market in this region.Request COVID Analysis on Osteoporosis Drugs Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=133Rise in prevalence of osteoporosis across the globe to Drive MarketHigher incidence & prevalence of osteoporosis across the world is the major driver for the growth of global osteoporosis market.For instance, according to International Osteoporosis Foundation, Osteoporosis causes more than 9 millionfractures annually, resulting in an osteoporotic fracture every 3 seconds and also it is estimated to affect 200 million women globally.Moreover growing aging population aged above 50 years are at the greatest risk of developing osteoporosis and related fractures due to hormonal changes.
So this rise in aging population also fuelling the growth of global market.Development of novel approaches for the treatment of osteoporosis by new drugs and increase in awareness among people for the early diagnosis & treatment are also some of the major factors for the growth of this market.Request Customization on Osteoporosis Drugs Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=133Bisphosphonates Segment to Dominate MarketBased on drug class, the global osteoporosis drugs market has been divided into Bisphosphonates, Calcitonin, RANK Ligand Inhibitors, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Sclerostin Inhibitor,and others.RANK ligand inhibitors dominated the market in2018 due to market exclusivity of branded drugs and its efficacy to treat osteoporosis.
The presence of few leading players is what makes the Asia Pacific butene-1 market increasingly consolidated and fairly consolidated, notes Transparency Market Research (TMR).
The competitive landscape features a low level of threat from the entry of new players.
Prominent names include ONGC Petro additions Limited, PetroChina Company Limited, China National Petroleum Corporation, China Petrochemical Corporation, and Petrochemical Corporation of Singapore (Private) Limited.The Asia Pacific butene-1 market is projected to expand at a CAGR of during the forecast period of 2016–2026.
This is attributed to the vast uptake of the compound in the production of high density polyethylene (HDPE) and linear low density polyethylene (LLDPE) products in the region.Geography-wise, China has emerged to the fore with its robust supplier base and it held the share of more than 65% in the regional market.
Substantial production capabilities in the country will help it retain its dominance throughout the assessment period.Vast Uptake in Producing Plastic Packaging Materials to Accentuate Regional MarketThe Asia Pacific butene-1 market has witnessed steady expansion over the past few years, riding on the back of the rising demand for plastic packaging materials.
The bold strides being made by the packaging industry in the region in the recent years has fueled the demand for butene-1.
The demand within the global digital health market is slated to rise in the times to follow.
There are no qualms about the importance of recording and tracking medical procedures conducted across the healthcare industry.
The success of the healthcare sector depends upon the coordination of medical and administrative activities.
It is important to use digital technologies in order to restore the integrity of medical and operational activities.
Therefore, the total volume of revenues within the global digital health market is projected to multiply in the years to follow.Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=12473The global digital health market is expected to grow at a formidable CAGR of 13.40% ovee the period between 2017 and 2025.
The geriatric population is the largest consumer of telemedicine facilities, and this is a key dynamic of market maturity.
Transparent Market Research (TMR) reflects the competitive landscape of the global pharmaceutical chemical spread across the globe.
New strategies are expected to be introduced to penetrate into the market.
Rising population and low mortality rate seems to be the reason for lucrative growth in the healthcare sector.
Swell in the geriatric population calls for increase in healthcare facilities.
Global pharmaceutical chemical market is projected to be flourishing in coming years due to rise in demand for drugs for non-communicable diseases.
However, developments in all the fields of healthcare facilities and rising geriatric population is projected to inflate the global pharmaceutical chemical market.Request for covid19 impact analysis –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=37685Disease Oriented Treatment to Push GrowthVarious therapy based applications are expected to increase the demand for global pharmaceutical chemical market.
Asphalt Additives Market: Key HighlightsThe global asphalt additives marketwas valued at ~ US$ 3.5 Mn in 2018, and is projected to expand at a CAGR of ~ 6% from 2019 to 2027.
Emerging warm mix asphalt (WMA) technology is anticipated to augment the global asphalt additives market during the forecast period.Asia Pacific was the leading region of the global asphalt additives market in The Asia Pacific asphalt additives market is estimated to continue its dominance in the global asphalt additives market during the forecast period.Key Drivers of the Asphalt Additives MarketThe demand for asphalt in road construction is expected to be driven by increasing environmental funding, legislative pressure to improve infrastructure, and growth in non-building construction activities, particularly in the highway & street segment.The demand for paving asphalt used in highways and streets has been rising, owing to the increase in government funding and growth in highway and street construction activities.
Request a Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=3238Shift in Focus Toward Bio-based Additives to Offer Attractive OpportunitiesBio-based additives are defined as additives made from biological sources.
Manufacturers are increasingly using eco-friendly products, owing to the rise in the awareness about the environment among consumers.Availability of Alternatives for Asphalt to Hamper the Asphalt Additives MarketBricks, pavers, cobblestone, concrete, permeable paving, gravel, and cement are some of the substitutes that are being increasingly used in place of bitumen.
Concrete is a highly employed product in the construction and maintenance of roads.The governments of several countries have been preferring the usage of concrete and cement for paving roads since the last few years.
This is expected to hamper the asphalt additives market.Asia Pacific Dominates the Asphalt Additives MarketAsia Pacific is expected to continue being a prominent market in the global asphalt additives market during the forecast period.
